Shono, Takefumi
Hyakutake, Hiroyuki
Funding for this research was provided by:
Mochida Pharmaceutical Co., Ltd. (None)
EA Pharma Co., Ltd. (None)
Article History
Received: 23 January 2020
Accepted: 30 March 2020
First Online: 21 April 2020
Competing interest
: TS has received funding from the following companies: Mochida Pharmaceutical Co., Ltd., and EA Pharma Co., Ltd. HH has no competing interests.
: This research protocol has the approval of the ethical review board of Yamauchi Clinic on July 2, 2019 (approval code 2019-06-00064). This protocol was also registered with the UMIN-CTR (UMIN000037285) on July 5, 2019. The study was conducted in compliance with the standard of the 1964 Helsinki Declaration, its later amendments, and Ethical Guidelines for Medical and Health Research Involving Human Subject or comparable ethical standards. Informed consent was obtained in the form of opt-out on the in-hospital bulletin board for 3 months.
: Not applicable.